Supernus Pharmaceuticals Inc. (SUPN)
NASDAQ · Healthcare
Supernus Pharmaceuticals Inc. Shareholder Equity 2010–2025
Supernus Pharmaceuticals Inc. annual shareholder equity history from 2011 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Supernus Pharmaceuticals Inc. shareholder equity as of December 31, 2025: 1.06B, a 2.51% increase year-over-year.
- Supernus Pharmaceuticals Inc. shareholder equity for 2025 were 1.06B, a 2.51% increase from 2024.
- Supernus Pharmaceuticals Inc. shareholder equity for 2024 were 1.04B, a 12.39% increase from 2023.
- Supernus Pharmaceuticals Inc. shareholder equity for 2023 were 921.5M, a 3.98% increase from 2022.
- Supernus Pharmaceuticals Inc. shareholder equity for 2022 were 886.2M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Supernus Pharmaceuticals Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $1,062 |
| 2024 | $1,036 |
| 2023 | $922 |
| 2022 | $886 |
| 2021 | $816 |
| 2020 | $745 |
| 2019 | $595 |
| 2018 | $453 |
| 2017 | $267 |
| 2016 | $192 |
| 2015 | $88 |
| 2014 | $41 |
| 2013 | $33 |
| 2012 | $58 |
| 2011 | $9 |
Supernus Pharmaceuticals Inc. Shareholder Equity — FAQ
Supernus Pharmaceuticals Inc. (SUPN) shareholder equity over the last 16 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see SUPN's shareholder equity history?
The chart and table above show Supernus Pharmaceuticals Inc.'s shareholder equity by year and by quarter, including the growth rate.